Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
ACS Omega ; 3(11): 14650-14664, 2018 Nov 30.
Article in English | MEDLINE | ID: mdl-30555984

ABSTRACT

Antimicrobial peptides are promising molecules in uprising consequences of drug-resistant bacteria. The prodomain of furin, a serine protease, expressed in all vertebrates including humans, is known to be important for physiological functions. Here, potent antimicrobial peptides were mapped by extensive analyses of overlapping peptide fragments of the prodomain of human furin. Two peptides, YR26 and YR23, were active against bacterial cells including MRSA-resistant Staphylococcus aureus and Staphylococcus epidermis 51625. Peptides were largely devoid of hemolytic and cytotoxic activity. Bacterial cell killing occurred as a result of the disruption of the permeability barrier of the lipopolysaccharide (LPS)-outer membrane and fragmentation of LPS into small micelles. Furthermore, antibacterial peptides specifically interacted with the negatively charged lipids causing membrane leakage and fusion. The YR26 peptide in sodium dodecyl sulfate micelles demonstrated a long-helix-turn-short-helix structure exhibiting restricted backbone motions. The cell-selective activity of the furin peptides and their unique mode of action on membranes have a significant potential for the development of therapeutics.

2.
Sci Rep ; 6: 30827, 2016 08 09.
Article in English | MEDLINE | ID: mdl-27501775

ABSTRACT

The Mycobacterium tuberculosis dihydrodipicolinate synthase (Mtb-dapA) is an essential gene. Mtb-DapA catalyzes the aldol condensation between pyruvate and L-aspartate-beta-semialdehyde (ASA) to yield dihydrodipicolinate. In this work we tested the inhibitory effects of structural analogues of pyruvate on recombinant Mtb-DapA (Mtb-rDapA) using a coupled assay with recombinant dihydrodipicolinate reductase (Mtb-rDapB). Alpha-ketopimelic acid (α-KPA) showed maximum inhibition of 88% and IC50 of 21 µM in the presence of pyruvate (500 µM) and ASA (400 µM). Competition experiments with pyruvate and ASA revealed competition of α-KPA with pyruvate. Liquid chromatography-mass spectrometry (LC-MS) data with multiple reaction monitoring (MRM) showed that the relative abundance peak of final product, 2,3,4,5-tetrahydrodipicolinate, was decreased by 50%. Thermal shift assays showed 1 °C Tm shift of Mtb-rDapA upon binding α-KPA. The 2.4 Å crystal structure of Mtb-rDapA-α-KPA complex showed the interaction of critical residues at the active site with α-KPA. Molecular dynamics simulations over 500 ns of pyruvate docked to Mtb-DapA and of α-KPA-bound Mtb-rDapA revealed formation of hydrogen bonds with pyruvate throughout in contrast to α-KPA. Molecular descriptors analysis showed that ligands with polar surface area of 91.7 Å(2) are likely inhibitors. In summary, α-hydroxypimelic acid and other analogues could be explored further as inhibitors of Mtb-DapA.


Subject(s)
Bacterial Proteins/metabolism , Bridged-Ring Compounds/pharmacology , Hydro-Lyases/metabolism , Ketones/pharmacology , Mycobacterium tuberculosis/drug effects , Mycobacterium tuberculosis/enzymology , Aspartic Acid/analogs & derivatives , Aspartic Acid/chemistry , Aspartic Acid/metabolism , Bacterial Proteins/antagonists & inhibitors , Bacterial Proteins/genetics , Binding Sites , Bridged-Ring Compounds/chemistry , Bridged-Ring Compounds/metabolism , Catalytic Domain , Crystallography, X-Ray , Enzyme Activation/drug effects , Enzyme Inhibitors/pharmacology , Hydro-Lyases/antagonists & inhibitors , Hydro-Lyases/genetics , Hydrogen Bonding , Inhibitory Concentration 50 , Ketones/chemistry , Ketones/metabolism , Kinetics , Molecular Docking Simulation , Molecular Dynamics Simulation , Pyruvic Acid/chemistry , Pyruvic Acid/metabolism , Recombinant Proteins/biosynthesis , Recombinant Proteins/genetics , Recombinant Proteins/isolation & purification
3.
Acta Crystallogr D Biol Crystallogr ; 69(Pt 12): 2543-54, 2013 Dec.
Article in English | MEDLINE | ID: mdl-24311595

ABSTRACT

Bacterial N-acetylmuramoyl-L-alanine amidases are cell-wall hydrolases that hydrolyze the bond between N-acetylmuramic acid and L-alanine in cell-wall glycopeptides. Rv3717 of Mycobacterium tuberculosis has been identified as a unique autolysin that lacks a cell-wall-binding domain (CBD) and its structure has been determined to 1.7 Šresolution by the Pt-SAD phasing method. Rv3717 possesses an α/ß-fold and is a zinc-dependent hydrolase. The structure reveals a short flexible hairpin turn that partially occludes the active site and may be involved in autoregulation. This type of autoregulation of activity of PG hydrolases has been observed in Bartonella henselae amidase (AmiB) and may be a general mechanism used by some of the redundant amidases to regulate cell-wall hydrolase activity in bacteria. Rv3717 utilizes its net positive charge for substrate binding and exhibits activity towards a broad spectrum of substrate cell walls. The enzymatic activity of Rv3717 was confirmed by isolation and identification of its enzymatic products by LC/MS. These studies indicate that Rv3717, an N-acetylmuramoyl-L-alanine amidase from M. tuberculosis, represents a new family of lytic amidases that do not have a separate CBD and are regulated conformationally.


Subject(s)
Amidohydrolases/chemistry , Amidohydrolases/metabolism , Mycobacterium tuberculosis/enzymology , Amino Acid Sequence , Crystallography, X-Ray , Humans , Models, Molecular , Molecular Sequence Data , Mycobacterium tuberculosis/chemistry , Mycobacterium tuberculosis/metabolism , Peptidoglycan/chemistry , Peptidoglycan/metabolism , Protein Conformation , Tuberculosis/microbiology , Zinc/metabolism
4.
Org Biomol Chem ; 10(41): 8326-35, 2012 Oct 03.
Article in English | MEDLINE | ID: mdl-22986997

ABSTRACT

Towards therapeutically viable mimics of host defense cationic peptides (HDCPs) here we report the design and synthesis of a small library, based on a novel hydrophobic-dipeptide-spermidine template. Lipidated sequences 11, 14, 15, 16, 18 and 19 exhibited potent activity against susceptible as well as drug resistant Gram-positive and Gram-negative bacterial strains. Structure-activity relationships of the template revealed a hydrophobicity window of 50-70% with minimum +2 charges to be crucial for activity and cell selectivity. Active sequences 14, 15 and 16 exhibited different modes of action based on dipeptide composition as revealed by studies on model membranes, intact bacterial cells and DNA. Further, severe damage to surface morphology of methicillin resistant S. aureus caused by 14, 15 and 16 at 10 × MIC was observed. The present study provides us two active sequences (14 and 16) with a membrane perturbing mode of action, cell selectivity to hRBCs and keratinocytes along with potent activity against clinically relevant pathogen MRSA. The designed template thus may prove to be a suitable probe to optimize sequences for better selectivity and potential to combat a wide range of drug resistant strains in further research.


Subject(s)
Anti-Bacterial Agents/chemical synthesis , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Dipeptides/chemistry , Drug Design , Linoleic Acid/chemistry , Spermidine/chemistry , Anti-Bacterial Agents/chemistry , Cell Line , Cell Survival/drug effects , Chromatography, High Pressure Liquid , Humans , Hydrophobic and Hydrophilic Interactions , Microbial Sensitivity Tests , Microscopy, Electron, Scanning , Molecular Structure
SELECTION OF CITATIONS
SEARCH DETAIL
...